Trial Details

Not Recruiting
Basic Information
Clinical ID c2427
Identifier CTRI/2021/03/032332
Trial Title Role of Faecal Microbiota Transplantation (FMT) in Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Health Condition 1: K51- Ulcerative colitis__
Interventions Intervention1: Fecal Microbiota Transplantation: Patients suffering from Ulcerative Colitis who have achieved remission either on FMT or with pharmacotherapy will be enrolled after obtaining informed consent. Donor faeces will be diluted in 200-300 ml normal saline. After proper blending, the slurry will be filtered and particulate matter will be removed. The resultant solution will be administered to the patient through colonoscopy, within 6 hours of preparation. Patient will be encouraged to retain the solution for as long as possible. These FMTs will be done once every two months and patients will be continued on their standard of care pharmacological maintenance regimen with 5-ASA compounds/ immunomodulators. Control Intervention1: Placebo: Patients suffering from Ulcerative Colitis who have achieved remission either on FMT or with pharmacotherapy will be enrolled after obtaining informed consent. Placebo will be administered to the patient through colonoscopy. Patient will be encouraged to retain the solution for as long as possible. These FMTs will be done once every two months and patients will be continued on their standard of care pharmacological maintenance regimen with 5-ASA compounds/ immunomodulators.
Participant Information
Sponsor Dayanand Medical College and Hospital
City -
Country/Region India
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional
Phase PHASE3
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -